| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.808 | 2.761 | 1.182 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Total Income - EUR | 2.808 | 2.761 | 1.182 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Total Expenses - EUR | 2.634 | 4.704 | 2.259 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Gross Profit/Loss - EUR | 173 | -1.943 | -1.077 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Net Profit/Loss - EUR | 89 | -2.026 | -1.112 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - | 0 |
Check the financial reports for the company - Antomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Current Assets | 2.201 | 104 | 3 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Cash | 2.201 | 104 | 3 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Shareholders Funds | 1.765 | -279 | -1.387 | -1.361 | -1.335 | -1.310 | -1.281 | -1.285 | - | 0 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | 40 |
| Debts | 437 | 383 | 1.390 | 1.361 | 1.335 | 1.310 | 1.281 | 1.285 | - | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8512 - 8512" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Antomed Srl